Supplemental Table I

Published: 3 August 2026| Version 1 | DOI: 10.17632/dvx4tr2bxs.1
Contributor:
Alexander Hammond

Description

This supplementary table provides an overview of the dermatologic adverse events associated with targeted therapy and immune checkpoint inhibitors, including their typical clinical presentations and management strategies.

Files

Categories

Dermatology, Oncology

Licence